As dysbiosis of the gut microbiome has been implicated in chronic inflammation and tumorigenesis, these observations suggest that microbiota–immune interactions may represent an additional pathway through which GLP-1 RA influences cancer risk. This evidence concerns the gene GLP1R and cancer.